Prescription drug · ANDA
Olmesartan medoxomil NDC 72603-951
Olmesartan medoxomil 20 mg/1 · Tablet · Oral · NorthStar RxLLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72603-951-01 | 72603095101 | 30 TABLET in 1 BOTTLE (72603-951-01)Marketed from Aug 7, 2026 | |
| 72603-951-02 | 72603095102 | 90 TABLET in 1 BOTTLE (72603-951-02)Marketed from Aug 7, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Olmesartan medoxomil
- Generic name (nonproprietary)
- olmesartan medoxomil
- Active ingredients
- Olmesartan medoxomil — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NorthStar RxLLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204814
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 72603-951_812d2d57-14d6-48a9-9687-85c2d125197eSPL ID 812d2d57-14d6-48a9-9687-85c2d125197eSPL set ID 812d2d57-14d6-48a9-9687-85c2d125197eRxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0372603952025
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472603095101followed by a unit qualifier and the quantityPackage 72603-0951-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, d…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 204814
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Olmesartan medoxomil | Olmesartan medoxomil 5 mg/1 | TabletOral | NorthStar RxLLC | 72603-950 |
| Olmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | TabletOral | NorthStar RxLLC | 72603-952 |
| Olmesartan medoxomil | Olmesartan medoxomil 5 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-178 |
| Olmesartan medoxomil | Olmesartan medoxomil 20 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-179 |
| Olmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-180 |
| Olmesartan medoxomil | Olmesartan medoxomil 20 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4598 |
| Olmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | TabletOral | A-S Medication Solutions | 50090-6632 |
| Olmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | TabletOral | A-S Medication Solutions | 50090-6633 |